Skip to main content

Table 3 Chemotherapy-induced toxicity (NCI-CTC version 2.0)

From: Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study

 

Grade 1, n

Grade 2, n

Grade 3, n

Grade 4, n

Neutropenia

0

3

1

0

Thrombocytopenia

2

1

0

0

Anemia

0

2

1

0

Diarrhea

10

4

1

0

Nausea-vomiting

10

9

2

0

Alopecia

3

0

0

0

Hand-foot syndrome

0

1

0

0

mucositis

6

0

2

0

Neurotoxicity

3

3

4

0

Asthenia

9

7

3

0

Allergic reaction

0

1

0

0

Maximum/patient (%)

4 (12,9)

15 (48,4)

6 (19,3)

0 (0)

  1. NCI-CTC: National Cancer Institute Common Toxicity Criteria.